Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ethinylestradiol and norgestrel only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and segesterone only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone and ethinylestradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and ferrous fumarate and norethisterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and ferrous fumarate and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+gestodene 30micrograms/75micrograms tablet (substance) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl estradiol + ferrous fumarate + norgestrel 0.03mg/75mg/0.3mg tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl estradiol + ferrous fumarate + norgestrel 0.03mg/75mg/0.3mg tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol betadex clathrate (substance) |
Is modification of (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |